Chris Garabedian
Portfolio Manager, Venture (PXV Fund)
Perceptive AdvisorsBoston, Massachusetts, United States
18 investmentsChris Garabedian is a Portfolio Manager, Venture (PXV Fund) at Perceptive Advisors based in Boston, Massachusetts, United States. Chris Garabedian has backed 18 companies, including Tellus Therapeutics, Nephraegis Therapeutics and CereVasc. Investment focus areas include Health Care, Autoimmune Diseases and Biotech.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (9)
| 1 | Tellus Therapeutics |
| 2 | Nephraegis Therapeutics |
| 3 | CereVasc |
| 4 | Landos Biopharma |
| 5 | Juno Diagnostics |
| 6 | Peroxitech Therapeutics |
| 7 | Zucara Therapeutics |
| 8 | AsclepiX Therapeutics |
| 9 | Shifa Biomedical |
Showing 1–9 of 9
Access Full Contact Information
Get Chris Garabedian's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.